205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.65%
Positive revenue growth while INTC is negative. John Neff might see a notable competitive edge here.
5.39%
Positive gross profit growth while INTC is negative. John Neff would see a clear operational edge over the competitor.
44.97%
EBIT growth above 1.5x INTC's 0.23%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
40.47%
Operating income growth above 1.5x INTC's 0.23%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
75.78%
Net income growth above 1.5x INTC's 5.13%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
78.95%
EPS growth above 1.5x INTC's 5.36%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
76.32%
Diluted EPS growth above 1.5x INTC's 7.41%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.88%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.37%
Dividend growth under 50% of INTC's 6.99%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
78.07%
OCF growth above 1.5x INTC's 8.61%. David Dodd would confirm a clear edge in underlying cash generation.
98.87%
Positive FCF growth while INTC is negative. John Neff would see a strong competitive edge in net cash generation.
128.08%
10Y revenue/share CAGR at 50-75% of INTC's 175.24%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
16.05%
5Y revenue/share CAGR under 50% of INTC's 55.82%. Michael Burry would suspect a significant competitive gap or product weakness.
30.73%
3Y revenue/share CAGR at 50-75% of INTC's 58.85%. Martin Whitman would question if the firm lags behind competitor innovations.
221.77%
10Y OCF/share CAGR 1.25-1.5x INTC's 186.36%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-1.55%
Negative 5Y OCF/share CAGR while INTC is at 54.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
60.07%
3Y OCF/share CAGR 1.25-1.5x INTC's 42.50%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
530.73%
Net income/share CAGR 1.25-1.5x INTC's 476.32%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
26.69%
Below 50% of INTC's 93.87%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
61.84%
3Y net income/share CAGR 75-90% of INTC's 77.47%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
55.49%
10Y equity/share CAGR at 50-75% of INTC's 85.63%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
28.39%
5Y equity/share CAGR at 50-75% of INTC's 40.73%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
34.19%
3Y equity/share CAGR at 75-90% of INTC's 39.89%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
707.91%
10Y dividend/share CAGR at 50-75% of INTC's 1025.22%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
113.40%
5Y dividend/share CAGR 1.25-1.5x INTC's 100.06%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
56.13%
3Y dividend/share CAGR similar to INTC's 61.71%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-0.37%
Firm’s AR is declining while INTC shows 11.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.96%
Inventory is declining while INTC stands at 8.46%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.09%
Asset growth above 1.5x INTC's 2.89%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.10%
BV/share growth above 1.5x INTC's 1.53%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
20.99%
We have some new debt while INTC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-3.54%
Our R&D shrinks while INTC invests at 3.66%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.66%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.